HealthQuill Articles by: HealthQuill
Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US regulatory body placed the experiments on full clinical hold, according to a company statement.
Drugs Health Pharma

Gilead Sciences puts last-stage blood cancer trials on hold after FDA order

HQ Team February 8, 2024: Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US

Read More
FDA has granted full approval for Janssen Biotech’s Balversa drug to treat metastatic bladder cancer after clinical trials showed “significant” improvement in overall survival rates.
Drugs Health Medical

Global cancer cases set to surge by 77% by 2050, new report warns

HQ Team February 6, 2024: A projection from the Global Cancer Observatory suggests that new cancer cases worldwide are set to surge by

Read More
Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.
Drugs Medical Pharma

‘Pharma firms manipulate patents to curb competition and drive prices’

A study conducted by researchers from Harvard University has revealed a concerning trend within the pharmaceutical industry— the widespread adoption of intricate patent

Read More
Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss firm access to a key drug for treating blood cancer.
Drugs Health Pharma

Novartis to buy MorphoSys for $2.9 billion to expand cancer portfolio

HQ Team February 6, 2024: Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss

Read More
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.
Drugs Health Medical

Oral insulin successfully tested on animals, human trials set for 2025

Bharti Jayshankar February 5, 2024: Scientists have developed a form of oral insulin, offering an alternative to traditional syringes or insulin pumps. The

Read More
Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5 billion plant in Germany to make devices for treating diabetes and obesity.
Drugs Health Pharma

Novo Nordisk buys 3 Catalent sites for $11bn to meet rising demand for Wegovy

HQ Team February 5, 2024: Novo Nordisk will acquire three manufacturing sites in an $11bn deal to expand its production of weightless drugs

Read More
Measles cases rose 30-fold in Europe with more than 30,000 people being infected by the contagious viral disease between January-October 2023 period, according to the WHO.
Drugs Health Pharma

Measles spreading rapidly across Europe, WHO calls for urgent curbs

HQ Team February 4, 2024: Measles cases rose 30-fold in Europe with more than 30,000 people being infected by the contagious viral disease

Read More
A child’s brain gets excessively or abnormally active when they are not treated for anxiety disorders, according to a study by the US National Institutes of Health.
Health Medical Pharma

CBT treatment may aid anxiety disorders in children: NIH study

HQ Team February 3, 2024: A child’s brain gets excessively or abnormally active when they are not treated for anxiety disorders, according to

Read More
Drugs Health Medical

Adolescent stress alters brain gene expression, leading to behavioral issues

HQ Team February 3, 2024: New research from the University of São Paulo’s Ribeirão Preto Medical School suggests that excessive stress during adolescence

Read More
endometriosis
Drugs Health Medical

Polycystic ovary syndrome linked to cognitive issues in women: Study

Bharti Jayshankar February 3, 2024: In a recent study published in the journal Neurology, researchers have uncovered a potential association between polycystic ovary

Read More